Location History:
- Taipei County, TW (2014)
- Taipei, TW (2011 - 2021)
Company Filing History:
Years Active: 2011-2021
Title: Chi-Ying Huang: Innovator in Cancer Treatment
Introduction
Chi-Ying Huang is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of cancer treatment, holding a total of 8 patents. His innovative approaches focus on utilizing herbal mixtures and pharmaceutical compositions to combat various forms of cancer.
Latest Patents
Among his latest patents, one notable invention is titled "Methods and compositions for treating non-small cell lung cancer." This invention is directed towards therapeutic methods and compositions that involve administering an effective amount of an extract or powder from a herbal mixture, optionally combined with an anti-cancer agent. The herbal mixture includes components from at least one species from the genera Red and White. Another significant patent is "Pharmaceutical composition for treatment of cancer using phenothiazine." This invention relates to the use of antipsychotic phenothiazine derivatives for cancer treatment. It provides methods for manufacturing a medicament and pharmaceutical compositions aimed at treating cancer and preventing or delaying cancer recurrence, particularly focusing on trifluoperazine and thioridazine.
Career Highlights
Chi-Ying Huang has worked with esteemed institutions such as National Yang Ming Chiao Tung University and the Industrial Technology Research Institute. His work has been pivotal in advancing cancer treatment methodologies and enhancing the understanding of herbal and pharmaceutical interactions in therapeutic applications.
Collaborations
Chi-Ying has collaborated with notable colleagues, including Hui-Chu Hsieh and Tzu-Ling Tseng, who have contributed to his research endeavors.
Conclusion
Chi-Ying Huang's innovative work in cancer treatment showcases his dedication to improving therapeutic options for patients. His patents reflect a blend of traditional herbal knowledge and modern pharmaceutical science, marking him as a significant figure in the field of medical innovation.